Internal challenges – and not regulatory ones – are the biggest barriers to better use of social media in pharma, according to a new survey of industry executives.

Communications firm Weber Shandwick conducted 12 in-depth telephone interviews with senior in-house pharma executives responsible for social media decisions in Europe, the US, Asia and Latin America.

Its resulting report, produced with Forbes Insights is ‘Digital Health: Building Social Confidence in Pharma’, and has 10 tips for pharma execs using social media to engage key audiences. 

The report identifies a number of what it calls ‘paradigm-shifting conclusions’. The most notable finding is that regulatory restrictions are no longer the primary barrier to social media engagement.

See on www.pharmafile.com